We have found that our article contained some mistakes in Tables 1, 2, 3, 4 and 5, and in Figures 1, 2. The correct tables and figures are shown below. We are publishing this Erratum to reflect those changes. The authors express regret for the errors.
Table 1.
Comparison of demographic data and clinical characteristics of the two groups
| Indicator | Observational group (n = 46) | Control group (n = 50) | χ2/t | P |
|---|---|---|---|---|
| Age (years) | 54.65±7.08 | 55.14±8.01 | 0.315 | 0.753 |
| Body mass index | 20.64±1.10 | 20.62±1.90 | 0.060 | 0.952 |
| Sex | 0.071 | 0.790 | ||
| Male | 27 | 28 | ||
| Female | 19 | 22 | ||
| Cirrhosis | 2.022 | 0.155 | ||
| Yes | 26 | 21 | ||
| No | 20 | 29 | ||
| Tumor diameter (cm) | 7.49±1.18 | 7.91±1.28 | 1.671 | 0.098 |
| Child-Pugh grading (n) | 0.534 | 0.465 | ||
| Grade A | 37 | 43 | ||
| Grade B | 9 | 7 | ||
| TNM stage (n) | 1.428 | 0.232 | ||
| Stage I | 33 | 41 | ||
| Stage II | 13 | 9 | ||
| CNLC staging (n) | 0.251 | 0.617 | ||
| Stage I | 30 | 35 | ||
| Stage II | 16 | 15 | ||
| Pathological type (n) | 0.209 | 0.648 | ||
| Hepatocellular carcinoma | 38 | 43 | ||
| Bile duct cell carcinoma | 8 | 7 | ||
| Hypertension | 5 | 10 | 1.515 | 0.218 |
| Stroke | 7 | 8 | 0.011 | 0.916 |
| Coronary heart disease | 6 | 7 | 0.019 | 0.891 |
| Distance between the lesion margins | 5.83±0.47 | 5.80±0.47 | 0.313 | 0.755 |
Table 2.
Comparison of surgical indicators between the two groups
| Indicator | Observational group (n = 46) | Control group (n = 50) | χ2/t | P |
|---|---|---|---|---|
| Operating time (min) | 90.17±5.11 | 98.16±4.90 | 7.821 | <0.001 |
| Intraoperative bleeding (mL) | 219.61±5.89 | 248.50±6.85 | 22.061 | <0.001 |
| Anal venting time (h) | 70.24±4.55 | 80.76±3.84 | 12.268 | <0.001 |
| Length of hospital stay (days) | 9.14±0.70 | 11.01±0.56 | 14.490 | <0.001 |
Table 3.
Comparison of liver function and AFP between the two groups
| Indicator | Time | Observational group (n = 46) | Control group (n = 50) | χ2/t | P |
|---|---|---|---|---|---|
| AST (U/L) | Before surgery | 58.67±4.14 | 58.05±3.94 | 0.759 | 0.450 |
| 1 week after surgery | 33.37±3.35 | 41.15±3.78 | 10.627 | <0.001 | |
| TBIL (U/L) | Before surgery | 31.48±3.11 | 31.32±3.50 | 0.232 | 0.817 |
| 1 week after surgery | 13.83±2.85 | 17.21±2.96 | 5.671 | <0.001 | |
| ALT (U/L) | Before surgery | 43.43±6.85 | 44.93±2.74 | 1.431 | 0.156 |
| 1 week after surgery | 26.78±3.02 | 32.77±3.44 | 9.020 | <0.001 | |
| γ-GT (U/L) | Before surgery | 68.18±3.46 | 68.67±3.40 | 0.687 | 0.494 |
| 1 week after surgery | 30.28±3.15 | 38.69±4.00 | 11.368 | <0.001 | |
| AFP | Before surgery | 213.19±10.13 | 211.75±5.78 | 0.863 | 0.390 |
| 1 week after surgery | 87.23±9.32 | 90.02±4.70 | 1.877 | 0.064 |
Note: AST: Aspartate transaminase; TBIL: Total Bilirubin; ALT: Alanine transaminase; γ-GT: γ-glutamyl transpeptidase; AFP: Alpha-fetoprotein.
Table 4.
Comparison of the incidence of complications between the two groups
| Indicator | Observational group (n = 46) | Control group (n = 50) | χ2/t | P |
|---|---|---|---|---|
| Pleural effusion | 2 | 3 | ||
| Biliary Leakage | 1 | 2 | ||
| Abdominal Infection | 1 | 2 | ||
| Pulmonary infection | 0 | 1 | ||
| Total incidence (%) | 4 | 8 | 1.169 | 0.280 |
Table 5.
Three-year recurrence and survival rates in the two groups
| Indicator | Observational group (n = 46) | Control group (n = 50) | χ2/t | P |
|---|---|---|---|---|
| Number of relapses | 4 | 5 | - | - |
| Recurrence rate (%) | 8.7% | 10% | 0.058 | 0.809 |
| Survival population | 39 | 40 | - | - |
Figure 1.
Kaplan Meier survival curve.
Figure 2.
Comparison of inflammation indicators between the two groups. A: hs-CRP; B: PCT; C: IgG. Note: PCT: procalcitonin; IgG: Immunoglobin G; hs-CRP: high-sensitivity C-reactive protein. *P<0.05 as compared with control group.